
Luka Nićin
VC at Pace Ventures | PhD in Molecular Medicine | Built founders-hunt.com
Berlin, Germany
Joined August 2025
Network
7.8K connectionsAARRBV
KYIUJC
DPZJKB
ASMMMS
KLSH
JCSP
KLSBKB
Summary
Luka Nićin is a highly accomplished professional blending deep scientific expertise in biomedicine and cardiovascular research with a strong aptitude for venture capital and biotech entrepreneurship. He holds a PhD in Biomedicine from Goethe University Frankfurt, where his doctoral work was recognized with the Rudi Busse Dissertation Prize, and has contributed to multiple peer-reviewed scientific publications in prestigious journals like Nature Cardiovascular Research and European Heart Journal. venturecafeberlin+4
Transitioning his scientific background into the business world, Dr. Nićin is currently a Venture Capitalist at Pace Ventures, where he focuses on health-tech and industrial-tech companies at the Pre-seed and Seed stages. He is also actively involved in advising startups and investing, as demonstrated by his roles at SPARK-BIH and Braingels. venturecafeberlin+3
Beyond his investment activities, Luka Nićin is a founder himself, having established NicinBio Strategy, a consultancy focused on biopharma asset evaluation. He also built founders-hunt.com, an AI-powered platform designed to identify promising stealth-mode founders, showcasing his innovative and entrepreneurial spirit. linkedin+1
Work
Education
Projects
Writing
A human cell atlas of the pressure-induced hypertrophic heart
January 1, 2022Reports insights into human cardiac hypertrophy at single-cell resolution, showing that intercellular communication, particularly via the Eph receptor tyrosine kinase EPHB1, is impaired in human cardiomyopathy.
Fibroblast‐mediated intercellular crosstalk in the healthy and diseased heart
January 1, 2022Single nuclei sequencing reveals novel insights into the regulation of cellular signatures in children with dilated cardiomyopathy
January 1, 2021Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
January 1, 2020Notes
GMGabriel Méhaigneriesaid they've seen
DLDr. Luka Nićin
make outstanding investment decisions as a venture capitalist.Oct 6, 2025
GMGabriel Méhaigneriesaid they've seen
DLDr. Luka Nićin
champion or lead investments in cutting-edge siRNA therapies for cardio metabolic disease.Aug 19, 2025